The U.S. Centers for Disease Control and Prevention (CDC) has said that a two-dose of Pfizer BioEntech’s COVID-19 vaccine can significantly reduce the risk of infection with omicron strains. For children aged 5-15, the CDC says children and adolescents aged 5-15 have been tested for COVID-19. weekly regardless of illness or not during July 64-Feb. 65
The CDC study found that the two doses of the Pfizer-BioEntech COVID-19 vaccine The risk of Omicron infection was reduced by 31% for children aged 5-11 years and by 59% for adolescents aged 12-15.
omicron infection About half of children and adolescents are not vaccinated. It is a subclinical infection.
The CDC’s Immunization Advisory Committee has recommended the use of Pfizer-BioEntech’s mRNA-based COVID-19 vaccine. For adolescents aged 12-15 on 12 May 20, 20 and for children 5-11 years old on 2 Nov 20.
#pfizer
#Omicron
image file